×
About 9,635 results

ALLMedicine™ Acute Pancreatitis Center

Research & Reviews  3,520 results

Development and validation of a prediction model for moderately severe and severe acute...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048464
World Journal of Gastroenterology; Yang DJ, Lu HM et. al.

May 19th, 2022 - The severity of acute pancreatitis in pregnancy (APIP) is correlated with higher risks of maternal and fetal death. To develop a nomogram that could predict moderately severe and severe acute pancreatitis in pregnancy (MSIP). Patients with APIP ad...

Acute Pancreatitis in Japan: Comparison of Before and After Revision of the Clinical Gu...
https://doi.org/10.1097/MPA.0000000000002009
Pancreas Ikeda M, Hamada S et. al.

May 19th, 2022 - Cases of acute pancreatitis (AP) are increasing worldwide, and mortality remains high in severe cases. In 2015, the Japanese guidelines for the management of AP were revised. We aimed to clarify the clinical practice of AP in Japan and its trend d...

Evaluating the accuracy of American Society for Gastrointestinal Endoscopy guidelines i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048789
World Journal of Gastroenterology; Tintara S, Shah I et. al.

May 19th, 2022 - Acute gallstone pancreatitis (AGP) is the most common cause of acute pancreatitis (AP) in the United States. Patients with AGP may also present with choledocholithiasis. In 2010, the American Society for Gastrointestinal Endoscopy (ASGE) suggested...

Ginsenoside Rg3 ameliorates acute pancreatitis by activating the NRF2/HO‑1‑mediated fer...
https://doi.org/10.3892/ijmm.2022.5144
International Journal of Molecular Medicine; Shan Y, Li J et. al.

May 19th, 2022 - Acute pancreatitis (AP) is an inflammatory disorder that has been associated with systemic inflammatory response syndrome. Ginsenoside Rg3 is a major active component of Panax ginseng, which has been demonstrated to exert potent protective effects...

see more →

Guidelines  9 results

Executive summary: WSES Guidelines for the management of severe acute pancreatitis.
https://doi.org/10.1097/TA.0000000000002691
The Journal of Trauma and Acute Care Surgery; Leppäniemi A, Tolonen M et. al.

May 28th, 2020 - Executive summary: WSES Guidelines for the management of severe acute pancreatitis.|2020|Leppäniemi A,Tolonen M,Tarasconi A,Segovia-Lohse H,Gamberini E,|therapeutic use,standards,standards,methods,standards,methods,standards,methods,standards,meth...

ESPEN guideline on clinical nutrition in acute and chronic pancreatitis.
https://doi.org/10.1016/j.clnu.2020.01.004
Clinical Nutrition (Edinburgh, Scotland); Arvanitakis M, Ockenga J et. al.

Feb 6th, 2020 - Both acute and chronic pancreatitis are frequent diseases of the pancreas, which, despite being of benign nature, are related to a significant risk of malnutrition and may require nutritional support. Acute necrotizing pancreatitis is encountered ...

The 2018 Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines f...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441166
BMC Infectious Diseases; Haddad N, Kanj SS et. al.

Mar 31st, 2019 - The Lebanese Society of Infectious Diseases and Clinical Microbiology (LSIDCM) is involved in antimicrobial stewardship. In an attempt at guiding clinicians across Lebanon in regards to the proper use of antimicrobial agents, members of this socie...

Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS):...
https://doi.org/10.1016/j.atherosclerosis.2018.06.814
Atherosclerosis Moulin P, Dufour R et. al.

Jul 7th, 2018 - Familial chylomicronaemia syndrome (FCS) is a rare, inherited disorder characterised by impaired clearance of triglyceride (TG)-rich lipoproteins from plasma, leading to severe hypertriglyceridaemia (HTG) and a markedly increased risk of acute pan...

Nutritional Considerations in Pediatric Pancreatitis: A Position Paper from the NASPGHA...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020697
Journal of Pediatric Gastroenterology and Nutrition; Abu-El-Haija M, Uc A et. al.

Jun 22nd, 2018 - Wide variations exist in how physicians manage the nutritional aspects of children affected by acute pancreatitis (AP), acute recurrent pancreatitis (ARP), and chronic (CP) pancreatitis. Better consensus for optimal management is needed. This cons...

see more →

Drugs  22 results see all →

Clinicaltrials.gov  101 results

To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin
https://clinicaltrials.gov/ct2/show/NCT05162014

May 13th, 2022 - To compare the risk of acute pancreatitis in patients with Type 2 diabetes mellitus (T2DM) newly initiating empagliflozin to that of patients newly initiating other oral non-incretin/non-Sodium glucose co-transporter-2 inhibitor (SGLT2i)-containin...

Safety and Tolerability of Pirfenidone in Acute Pancreatitis
https://clinicaltrials.gov/ct2/show/NCT05350371

Apr 28th, 2022 - The study is a Randomized Pilot clinical trial evaluating safety and tolerability of pirfenidone in patients with predicted moderately severe to severe acute pancreatitis. There are built in secondary end-points for efficacy. The patients with acu...

Hypertriglyceridemia-associated Acute Pancreatitis: Apheresis Vs. Conservative Treatment
https://clinicaltrials.gov/ct2/show/NCT04708925

Apr 13th, 2022 - Background: Hypertriglyceridemia causes 1-7% of all acute pancreatitis cases. The mechanism by which excess lipids in the blood cause pancreatitis is not entirely clear. The hypothesis is, that the enzyme lipase, which originates in the pancreas, ...

Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid
https://clinicaltrials.gov/ct2/show/NCT04291599

Apr 11th, 2022 - Acute pancreatitis (AP) is the most common pancreatic disease of childhood with an increasing incidence estimated at 13.2 cases in 100,000 children per year. Given the dearth of pediatric literature, most pediatric providers often rely on diagnost...

PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
https://clinicaltrials.gov/ct2/show/NCT05310409

Apr 4th, 2022 - This project will measure the impact of a recently validated patient-reported outcome measure for acute pancreatitis, PAN-PROMISE, to detect post-ERCP pancreatitis symptoms and capture its morbidity. We will compare the change of PAN-PROMISE befor...

see more →

News  196 results

Pancreatic Cancer: Yearly Monitoring of Cystic Lesions in Doubt
https://www.medscape.com/viewarticle/971311

Mar 31st, 2022 - PARIS, France — Fewer than 1% of patients with intraductal papillary mucinous neoplasms (IPMNs) of the branch ducts develop adenocarcinoma after 5 years of follow-up monitoring, according to a French observational study. These findings were presen...

Incidence and Outcomes of Splanchnic Vein Thrombosis in Patients with Pancreatitis
https://www.medscape.com/viewarticle/962149

Nov 3rd, 2021 - Takeaway The incidence of splanchnic vein thrombosis (SVT) remains significant in patients with acute pancreatitis. Treatment with anticoagulants improved the rate of recanalisation but increased the risk of haemorrhagic complications, without inc...

The Risk Factors Behind Infected Pancreatic Necrosis' Deadly Toll
https://www.medscape.com/viewarticle/954971

Jul 19th, 2021 - Patients with infected pancreatic necrosis (IPN) are more likely to experience organ failure and mortality, which makes identifying them as quickly as possible especially crucial. A new study aimed to make this task a bit easier by categorizing th...

The risk factors behind infected pancreatic necrosis’ deadly toll
https://www.mdedge.com/internalmedicine/article/242823/gastroenterology/risk-factors-behind-infected-pancreatic-necrosis
Heidi Splete

Jul 13th, 2021 - Patients with infected pancreatic necrosis (IPN) are more likely to experience organ failure and mortality, which makes identifying them as quickly as possible especially crucial. A new study aimed to make this task a bit easier by categorizing th.

Management of Intraductal Papillary Mucinous Neoplasms Still Unclear
https://www.medscape.com/viewarticle/951838

May 26th, 2021 - NEW YORK (Reuters Health) - Two studies addressing the management of intraductal papillary mucinous neoplasms (IPMNs) conclude that current guidelines don't provide enough evidence on when to observe and when to excise them. Both studies were publ...

see more →

Patient Education  6 results see all →